InvestorsHub Logo

ChaseDog31

08/18/20 9:42 AM

#16725 RE: Ecomike #16722

I'm thinking any deal would be structured as a smaller monthly licensing fee with NDTP getting points on the back end for any drugs brought to market using their tech.

1.5 or 2 points could be massive if spread across numerous established drugs.